Starten Sie Ihre Suche...


Wir weisen darauf hin, dass wir technisch notwendige Cookies verwenden. Weitere Informationen
Publikationen
Ergebnisse pro Seite:  10

Beyer, Mandy; Romanski, Annette; Mustafa, Al-Hassan M. et al.

HDAC3 Activity is Essential for Human Leukemic Cell Growth and the Expression of beta-catenin, MYC, and WT1

CANCERS. Bd. 11. H. 10. 2019


Pons, Miriam; Nagel, Georg; Zeyn, Yanira et al.

Human Platelet Lysate as Validated Replacement for Animal Serum to Assess Chemosensitivity

ALTEX-ALTERNATIVES TO ANIMAL EXPERIMENTATION. Bd. 36. H. 2. 2019 S. 277-288



Liebl, M. C.; Hofmann, T. G.

Identification of responders to immune checkpoint therapy: which biomarkers have the highest value?

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. Bd. 33. 2019 S. 52-56


Kraus, Alexander; McKeague, Maureen; Seiwert, Nina et al.

Immunological and mass spectrometry-based approaches to determine thresholds of the mutagenic DNA adduct O-6-methylguanine in vivo

ARCHIVES OF TOXICOLOGY. Bd. 93. H. 2. 2019 S. 559-572


Neitzel, Carina; Seiwert, Nina; Goeder, Anja et al.

Lipoic Acid Synergizes with Antineoplastic Drugs in Colorectal Cancer by Targeting p53 for Proteasomal Degradation

CELLS. Bd. 8. H. 8. 2019


Kitsera, Nataliya; Rodriguez-Alvarez, Marta; Emmert, Steffen et al.

Nucleotide excision repair of abasic DNA lesions

NUCLEIC ACIDS RESEARCH. Bd. 47. H. 16. 2019 S. 8537-8547


Guo, Haihong; Treude, Fabian; Kraemer, Oliver H. et al.

PAR-4 overcomes chemo-resistance in breast cancer cells by antagonizing cIAP1

SCIENTIFIC REPORTS. Bd. 9. 2019


Tomicic, M.; Steigerwald, C.; Rasenberger, B. et al.

Survivin inhibitor LLP3 sensitizes colorectal cancer cells to irinotecan in the context of a specific XAF1/p53 signature

NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY. Bd. 392. 2019 S. S9-S9